XDWY:XETRA:XETRA-Xtrackers MSCI World ESG Screened UCITS ETF 1D (EUR)

ETF | Others |

Last Closing

USD 23.06

Change

+0.08 (+0.33)%

Market Cap

USD 0.09B

Volume

3.37K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.24 (+0.48%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.09 (+0.56%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.11 (+0.39%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.16 (+0.57%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.17 (+0.68%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.38 (+0.84%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+1.36 (+0.97%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.29 (+0.57%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.32 (+0.31%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.60 (+0.27%)

USD 80.38B

ETFs Containing XDWY:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.54% 80% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.54% 80% B- 79% B-
Trailing 12 Months  
Capital Gain 28.99% 80% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.99% 79% B- 79% B-
Trailing 5 Years  
Capital Gain 29.94% 56% F 60% D-
Dividend Return 10.84% 61% D- 48% F
Total Return 40.79% 63% D 63% D
Average Annual (5 Year Horizon)  
Capital Gain 7.24% 56% F 56% F
Dividend Return 8.37% 60% D- 58% F
Total Return 1.13% 76% C+ 55% F
Risk Return Profile  
Volatility (Standard Deviation) 11.96% 52% F 62% D
Risk Adjusted Return 69.97% 65% D 69% C-
Market Capitalization 0.09B 30% F 27% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.